Related donor transplants: Has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?

Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant, Center for International Blood and Marrow Transplant Research

Research output: Contribution to journalArticlepeer-review


We sought to identify whether posttransplantation cyclophosphamide (PT-Cy) reduces or eliminates the detrimental impact of HLA mismatching on outcomes of HLA-haploidentical related donor transplantation for acute leukemia. Data from 2143 donor-recipient pairs (n = 218 haploidentical sibling; n = 218 offspring; n = 1707 HLA-matched sibling) with acute myeloid or lymphoblastic leukemia were studied. All received a calcineurin inhibitor for graft-versus-host disease (GVHD) prophylaxis while high-dose PT-Cy was also given to recipients of haploidentical transplant. Patient age correlated with donor-recipient relationship: haploidentical siblings donated to patients aged 18 to 54 years whereas offspring donated to patients aged 55 to 76 years. Therefore, transplant outcomes were examined separately in the 2 patient age groups. In patients aged 18 to 54 years, there were no significant differences in outcomes except chronic GVHD, which was lower after haploidentical sibling compared to HLA-matched sibling transplant (hazard ratio [HR], 0.63; P, .001). In patients aged 55 to 76 years, despite lower chronic GVHD (HR, 0.42; P, .001), graft failure (14% vs 6%; P = .003), nonrelapse mortality (HR, 1.48; P = .02), and overall mortality (HR, 1.32; P = .003) were higher after transplant from offspring compared with an HLA-matched sibling. These data demonstrate a superior outcome in older recipients when using an HLA-matched sibling instead of offspring, although there were differences in transplant platforms (GVHD prophylaxis and graft type) between the 2 groups. Validation of these findings requires a prospective randomized trial wherein the transplant platforms can be closely matched.

Original languageEnglish
Pages (from-to)1180-1186
Number of pages7
JournalBlood advances
Issue number11
StatePublished - 12 Jun 2018


Dive into the research topics of 'Related donor transplants: Has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?'. Together they form a unique fingerprint.

Cite this